Krebs Biochemicals & Industries Limited is a company based in Hyderabad, India that specializes in the production and sale of active pharmaceutical ingredients. With a focus on biotech processes, the company develops products for use in medicine, agriculture, and industry. Among its range of offerings are androstenedione, lovastatin, and simvastatin, which are utilized in anti-cholesterol and steroid intermediate applications. Additionally, Krebs Biochemicals develops various other products such as amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine, which serve purposes in anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. Furthermore, the company provides contract manufacturing services to large pharmaceutical and multinational companies. Established in 1991, Krebs Biochemicals continues to be a prominent player in the industry.
Navigation section
Krebs Biochemicals and Industries Limited
- 108.82 -4.78(-4.21%) 108.65 -5.50(-4.82%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 108.81 108.65 | 115.80 115.50 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 60.35 (28-Mar-2024) 60.00 (01-Apr-2024) | 129.07 (27-Nov-2024) 129.00 (27-Nov-2024) |
- Open
- 115.70 115.00
- Previous Close
- 113.60 114.15
- Volume
- 0.42
- Total Traded value
- 0.47 (₹ Lakhs)
- Upper circuit
- 124.96 82.60
- Lower circuit
- 102.24 74.74
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 0 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹2.35 Cr |
| PE Ratio (TTM): | -11.31 |
| PB Ratio: | -2.06 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | 18.25 |
| EPS (TTM): | -10.09 |
| Book Value: | -50.61 |
| Face Value: | 10.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 14.89 Cr | 10.58 Cr | 11.46 Cr | 9.09 Cr | 20.94 Cr |
| Profit | -3.57 Cr | -5.33 Cr | -6.94 Cr | -5.55 Cr | -4.06 Cr |
| Expense | 18.64 Cr | 15.95 Cr | 18.59 Cr | 14.67 Cr | 25.28 Cr |
| Comprehensive income | -3.57 Cr | -5.33 Cr | -6.62 Cr | -5.55 Cr | -4.06 Cr |
| EPS | -1.66 | -2.47 | -3.07 | -2.58 | -1.88 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Krebs Biochemicals and Industries Limited | Jan, 1996 May, 2000 | Pharmaceuticals Pharmaceuticals | KREBSBIO KREBSBIO |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Krebs Biochemicals and Industries Limited FAQ's
What is the range of today's stock performance for Krebs Biochemicals and Industries Limited?
Today's stock performance witnessed a fluctuation from a minimum of 108.81 on the NSE (National Stock Exchange) to a maximum of 115.80. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 108.65 to a high of 115.50.
What are the 52-week low and high values for Krebs Biochemicals and Industries Limited?
The stock's performance over the past 52 weeks reveals a low of 60.35 (occurred on 28-Mar-2024) and a high of 129.07 (achieved on 27-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 60.00 (on 01-Apr-2024), and the 52-week high is 129.00 (on 27-Nov-2024).
What was the opening and previous closing prices for Krebs Biochemicals and Industries Limited?
The stock's performance over the past 52 weeks reveals a low of 60.35 (occurred on 28-Mar-2024) and a high of 129.07 (achieved on 27-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 60.00 (on 01-Apr-2024), and the 52-week high is 129.00 (on 27-Nov-2024).
What is the total volume and traded value for Krebs Biochemicals and Industries Limited for the day?
The total volume is 0, and the total traded value is 0.47 (₹ Lakhs).
What are the upper and lower circuit limits for Krebs Biochemicals and Industries Limited?
The upper circuit limit is 124.96, and the lower circuit limit is 102.24.
What is the market cap and PE ratio for Krebs Biochemicals and Industries Limited?
The market cap is ₹2.35 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Krebs Biochemicals and Industries Limited?
The PB ratio is -2.15, industry P/E is 0.00 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Krebs Biochemicals and Industries Limited?
ROE is 18.25, EPS is -10.09, book value is -50.61
What are the revenue and profit figures for the latest quarter and previous quarters for Krebs Biochemicals and Industries Limited?
In Sep 2023, Revenue is ₹148901000.00, and Profit is ₹-35713000.00. In Jun 2023, Revenue is ₹105813000.00, and Profit is ₹-53329000.00.
When was Krebs Biochemicals and Industries Limited listed, and what industry does it belong to?
The company, Krebs Biochemicals and Industries Limited, was listed in Jan 1996 and belongs to the Pharmaceuticals industry. Its NSE symbol is KREBSBIO.
What is the current shareholding pattern of the Krebs Biochemicals and Industries Limited?
As of latest available update, promoters hold 72.74%, the public holds 27.26%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 94
